Stephens R W, Golder J P, Fayle D R, Hume D A, Hapel A J, Allan W, Fordham C J, Doe W F
Blood. 1985 Aug;66(2):333-7.
Adherent monolayer cultures of human blood monocytes, peritoneal macrophages, bone marrow macrophages, and colonic mucosa macrophages were examined for their ability to produce and secrete minactivin, a specific inactivator of urokinase-type plasminogen activator. All except colonic mucosa macrophages produced and secreted appreciable amounts of minactivin, but only blood monocytes were stimulated by muramyl dipeptide (adjuvant peptide) to increase production. The minactivin from each of these populations could be shown to preferentially inhibit urokinase-type plasminogen activator and not trypsin, plasmin, or "tissue"-type plasminogen activator (HPA66). A plasminogen-activating enzyme present in monocyte cultures appeared unaffected by the presence of minactivin and could be shown to be regulated independently by dexamethasone.
对人血单核细胞、腹腔巨噬细胞、骨髓巨噬细胞和结肠黏膜巨噬细胞的贴壁单层培养物进行了检测,以考察它们产生和分泌米那替丁(一种尿激酶型纤溶酶原激活物的特异性灭活剂)的能力。除结肠黏膜巨噬细胞外,其他细胞均能产生并分泌可观量的米那替丁,但只有血单核细胞受到胞壁酰二肽(佐剂肽)刺激后产量增加。这些细胞群体产生的米那替丁均可显示出优先抑制尿激酶型纤溶酶原激活物,而不抑制胰蛋白酶、纤溶酶或“组织”型纤溶酶原激活物(HPA66)。单核细胞培养物中存在的一种纤溶酶原激活酶似乎不受米那替丁的影响,并且可显示其受地塞米松的独立调节。